Exploring Radiation-Induced Toxicities from a Nursing Perspective

Translate to Spanish or other 102 languages!

Radiation therapy uses high doses of radiation to destroy cancer cells. Image for illustration purposes
Radiation therapy uses high doses of radiation to destroy cancer cells. Image for illustration purposes

Mega Doctor News

- Advertisement -

By Rutgers Cancer Institute of New Jersey

Newswise — New Brunswick, N.J.  – Radiation therapy uses high doses of radiation to destroy cancer cells. Unfortunately, receiving this type of treatment for cancers in the pelvic region can cause painful inflammation of the rectum, called radiation proctitis (RP). Dorothy N. Pierce, DNP, NP-C, CRN, CBCN, a nurse practitioner in the Department of Radiation Oncology at Rutgers Cancer Institute of New Jersey, highlights the role of advanced practice nurses (APNs) in providing supportive care for patients experiencing RP, which will be presented as a poster at the upcoming 2022 American Association of Nurse Practitioner (AANP) National Conference in Orlando, Florida from June 21 to June 26.

Why is this topic important to explore? 

- Advertisement -

Most patients diagnosed with cancer will receive radiation therapy sometime during their cancer journey. Regrettably, an unusual number of patients who receive pelvic radiation therapy for various pelvic malignancies suffer from significant radiation-induced toxicities that impact the patient’s quality of life (QOL). In addition, these survivors exhibit a range of psychological, physical, and supportive care needs that exist many years after diagnosis and completion of active treatment. Although new devices and emerging radiation therapy technologies exist, radiation side effects can occur months to years after treatment ends. Therefore, radiation oncology (RO) clinicians can best prepare survivors with education about long-term and late occurring effects such as RP. Likewise, non-oncology clinicians should be mindful of RP when assessing pelvic RT patients who present with diarrhea and bleeding.

What role do nurses play in providing support for patients suffering from RP?

Radiation oncology nurses play a crucial role in assessing contributing factors and providing effective symptoms management, information, and counseling about radiotherapy side effects to patients and their caregivers. Primarily patient-related risk factors may include genomic, previous abdominal surgery, tumor size, and inflammatory bowel disease. In addition, RO nurses are well situated to offer detailed education information to patients who received radiation therapy to the pelvic region.

What are the implications of your findings? 

- Advertisement -

Many patients diagnosed with cancer face numerous psychosocial issues at diagnosis, pre-radiation, during, and post-treatment. The multidisciplinary team approach to cancer care is essential. The RO APNs have unique responsibilities such as disease-specific patient assessments, patient education, site-specific side effects management, and medication management, making active and post-treatment follow-up care essential. As radiotherapy continues to make technological advances and the opportunity for curative intent suggests that the role of RO nurses will become even more critical. Thus, advancing knowledge and research is paramount to site-specific side effects in this area to stay current.  

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Robotic Surgery Program Expanded at STHS McAllen

From smaller incisions and less pain to shorter hospital stays and faster recovery times, robotic-assisted surgery is changing the way patients experience surgical care.

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen. FULL TO CAPACITY. NO MORE ROOM.

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

Highway Crash Leads to Unexpected STC Connection

What began as a flat tire on the side of a highway turned into a frightening collision and an unexpected encounter for South Texas College faculty member Jesus Amaya, when the paramedic who responded to the scene turned out to be one of STC’s graduates.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.
- Advertisement -